Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Galantamine Hydrobromide Sustained-release Tablets

Approval Number

国药准字H20110108

Company国药集团宜宾制药有限责任公司

Registration Date

August 26, 2021

Previous Approval Numbers

国药准字H20110108

Drug Information

Generic Name

氢溴酸加兰他敏缓释片

Dosage Form

片剂

Strength

10mg

Drug Type

化学药品

Registration Date

August 26, 2021

Company Information

Applicant Company

Company Name国药集团宜宾制药有限责任公司

Company Address

宜宾罗龙工业集中区滨江东路1号

Manufacturing Company

Company Name国药集团宜宾制药有限责任公司

Company Address

宜宾罗龙工业集中区滨江东路1号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy